Clinical Trial Update: Dynamic 68Ga-PSMA and 18F-FDG PET/CT Analysis Prior to 177Lu-PSMA [NA]

View source ↗

Summary

This clinical trial update describes a recruiting study evaluating dynamic Ga-68 PSMA and 18F-FDG PET/CT imaging before Lu-177 PSMA therapy in metastatic prosta…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prostate Cancer

Drugs mentioned

• 18F-FDG (fluorodeoxyglucose F-18)
• Ga-68 PSMA (Gallium-68 PSMA-11)
• Lu-177 PSMA-617 (Pluvicto) (Lutetium-177 PSMA-617)

Snippet

Sponsor: Centre Henri Becquerel | Conditions: Prostate Cancer Metastatic | NA | Status: RECRUITING